Current NDC auxiliary source row compounder:39

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-5550
Product Ndc: 72934-5550
Product Ndc Digits: 729345550
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Batizia
Proprietary Name Suffix: [empty]
Nonproprietary Name: 351022 LIDOCAINE 2% / MUPIROCIN 2%
Dosage Form Name: OINTMENT
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: LIDOCAINE; MUPIROCIN
Active Ingredients Info: 2 g/100 g; 2 g/100 g
History Active Ingredients Raw: LIDOCAINE; MUPIROCIN
History Active Ingredients Info Raw: 2 g/100 g; 2 g/100 g
History Dosage Raw: OINTMENT
Dea Schedule: [empty]
Package Ndc Raw: 72934-5550-2
Package Ndc: 72934-5550-2
Package Ndc Digits: 7293455502
Package Ndc11: 72934555002
Package Description: 30 g in 1 BOTTLE, PUMP (72934-5550-2)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:39
Source Row Number: 39
Source Row Hash: 3849e2a994cdd2e11f9693110340cbe78d9387b5862fc966aa5c7247cf5a4ffc
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-5550",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "LIDOCAINE; MUPIROCIN",
    "DOSAGEFORMNAME": "OINTMENT",
    "NDCPACKAGECODE": "72934-5550-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Batizia",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "351022 LIDOCAINE 2% / MUPIROCIN 2%",
    "PACKAGEDESCRIPTION": "30 g in 1 BOTTLE, PUMP (72934-5550-2) ",
    "ACTIVEINGREDIENTSINFO": "2 g/100 g; 2 g/100 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:39
Source Row Number: 39
Status Scope: package
Lookup Ndc: 72934-5550-2
Lookup Ndc Digits: 7293455502
Product Ndc: 72934-5550
Product Ndc Digits: 729345550
Package Ndc: 72934-5550-2
Package Ndc Digits: 7293455502
Package Ndc11: 72934555002
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 3849e2a994cdd2e11f9693110340cbe78d9387b5862fc966aa5c7247cf5a4ffc
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09